about
Temozolomide for high grade gliomaChemotherapy wafers for high grade gliomaTemozolomide for High Grade GliomaChemotherapeutic wafers for High Grade GliomaSurgical resection and whole brain radiation therapy versus whole brain radiation therapy alone for single brain metastasesTight Junctions and the Tumor MicroenvironmentAdvance Care Planning in Glioblastoma PatientsProspects of immune checkpoint modulators in the treatment of glioblastomaImmunotherapy response assessment in neuro-oncology: a report of the RANO working groupDexamethasone alleviates tumor-associated brain damage and angiogenesisDexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrierInterstitial fluid flow in cancer: implications for disease progression and treatment.Supportive management of patients with brain tumors.Dexamethasone acts as a radiosensitizer in three astrocytoma cell lines via oxidative stress.A T1 hyperintense perilesional signal aids in the differentiation of a cavernous angioma from other hemorrhagic masses.Chemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.Central neurotoxicity in cancer chemotherapy: pharmacogenetic insights.Posterior reversible encephalopathy syndrome: clinicoradiological spectrum and therapeutic strategies.Corticosteroids in palliative care - perspectives of clinicians involved in prescribing: a qualitative studyGlucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONOThe impact of dietary isoflavonoids on malignant brain tumorsCorticosteroid prescribing in palliative care settings: a retrospective analysis in New ZealandPerioperative management of patients with lung carcinoma and cerebral metastases.Meningeal carcinomatosis diagnosed during stroke evaluation in the emergency departmentThe role of cytokines and inflammatory cells in perinatal brain injury.Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probesDexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.Dexamethasone potentiates in vitro blood-brain barrier recovery after primary blast injury by glucocorticoid receptor-mediated upregulation of ZO-1 tight junction protein.Can a broken barrier be repaired?Neuroprotection in primary brain tumors: sense or nonsense?Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution.Brain metastasis from non-seminomatous germ cell tumor of the testis.Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas.Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.Pazopanib therapy for cerebellar hemangioblastomas in von Hippel-Lindau disease: case report.Occludin expression in brain tumors and its relevance to peritumoral edema and survival.Drug interactions at the blood-brain barrier: fact or fantasy?Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.Health-related quality of life in high-grade glioma patients.
P2860
Q24197645-A6F7041F-57FA-4322-901D-EC22D3BCDF35Q24235641-A247203D-571E-4A0F-B5D1-ABF582E5FB87Q24241222-1A868E07-7BC2-4803-AAE3-1DC9CAFD2732Q24242222-EB532CF4-75F9-4C22-8E6B-98241039DB90Q24245168-DEB85780-0F4D-438D-9746-9ABE9E5B286CQ26740056-74504290-EA36-4CB7-A099-13B0134093C3Q28067320-D128A5A7-F191-469B-ADDE-2F28D5A25BB9Q28081371-C8C3E041-5337-4EE9-93D1-9A2DE917D77FQ28083009-29EE4B92-8A3C-457E-A1F7-25B3819BD1ACQ28542092-C81A8270-15B9-452C-AFA6-44076DD90843Q28572624-51520AB7-13C6-4744-A25C-78C82417ED24Q30411142-EA719800-FE11-4939-9893-6A0A5BD130D1Q30444752-5FC95C9B-B34F-4AE2-81D7-63496BDC4940Q30658148-4F587592-DF26-46DB-95A2-C2066C613A85Q31137813-97FA7831-B584-4370-9962-02B699BBCDFCQ33415517-E34CD6A3-A964-495D-AA2A-2850104FB0F1Q33857581-0FD8B217-D68B-4A1C-8C88-EDFC31D66266Q34190737-1D2B628A-74AD-4C20-A8CC-684644868D94Q34587332-6F44BF36-F1D1-49F9-92A2-0ECDA193C6C8Q34703697-ADB0A304-0A25-4DE4-93DF-DF41B8BE35B7Q35000427-A2ACA06E-C5A6-4030-A837-60E2A00DD41DQ35113993-A3671E0E-FE89-4B03-BF6A-10E5CD62C543Q35146981-1AB0F16D-3F71-4E11-80EA-9EDFAE67A0E6Q35426813-905BB8C5-5FEF-4FB3-A486-C0ADFF978879Q35864361-14FAFB5C-4D47-48DE-BC9B-BBCD81E04BF4Q35945287-06D253CF-70EF-49DE-B1FF-567CD98BC9E2Q36169726-AD8F0993-8F5C-4A5A-9CDC-D047383342D0Q36267273-462BDD1E-8981-4ECC-8CB1-70EB05E76F59Q36438273-BA275B41-9C60-4A21-B3CE-43F96FBCB010Q36492361-94DC3E39-D170-4C03-893F-A8B160FC079FQ36584322-A8C2A044-8B9D-4BBC-A7AE-597B3E04E7A9Q37004670-9A4CE3ED-A92B-4462-86D8-E54BBB34AA42Q37118932-33C5F1F2-84F7-4EA3-A2C7-6D3112147EACQ37187685-95D7CB7C-1667-4139-9EB8-B69338F11408Q37210210-339C624E-D8BE-45C2-BF30-588796FAC47EQ37275838-AB4C00C5-1CC4-4F6E-AC43-053411E2245AQ37341757-C54A4128-98BA-4E55-9BF9-ED24F23B1E6EQ37362486-10D21AD0-0821-4C89-8C1C-6C7A8CB775AFQ37454341-8ED76818-EF39-4570-B9C6-DCE51E596E3BQ37525886-4771E6D6-7906-4192-A250-EEB5B55A2E78
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The management of brain edema in brain tumors.
@ast
The management of brain edema in brain tumors.
@en
type
label
The management of brain edema in brain tumors.
@ast
The management of brain edema in brain tumors.
@en
prefLabel
The management of brain edema in brain tumors.
@ast
The management of brain edema in brain tumors.
@en
P1476
The management of brain edema in brain tumors.
@en
P2093
Charles J Vecht
Evert C A Kaal
P304
P356
10.1097/01.CCO.0000142076.52721.B3
P577
2004-11-01T00:00:00Z